Front Page News

Cure SMA Receives NIH Grant

May 27, 2015
Posted in , , ,

For the seventh consecutive year, Cure SMA has received a grant from the National Institutes of Health (NIH) for the SMA Researcher Meeting. This year’s […]

In Memory of Ken Emerson

May 26, 2015
Posted in ,

Cure SMA mourns the loss of Ken Emerson, volunteer at the Cure SMA National Office. Since his grandson Ryan was diagnosed with SMA type III, […]

21st Century Cures Unanimously Passes Committee

May 22, 2015
Posted in ,

Yesterday, the 21st Century Cures bill was unanimously passed by the House Energy and Commerce Committee. 21st Century Cures would overhaul how the Food and […]

Collaborative Ways Cure SMA is Driving Research Results

May 19, 2015
Posted in , , ,

Much as families in our community often work together to start a chapter, organize an event, or raise awareness of SMA, researchers must work together […]

Meet the SMA Family that Helped Inspire 21st Century Cures

May 15, 2015
Posted in ,

In a recent update on the 21st Century Cures Initiative, we shared how the SMA community has helped inspire this legistlation. Chairman Fred Upton has […]

Cytokinetics and Astellas Release Further Details on Upcoming Phase 2 Trial

May 14, 2015
Posted in ,

Cytokinetics, in partnership with Astellas, has officially announced that recruitment will begin in the second half of 2015 for a Phase 2 clinical trial testing […]

Cure SMA Joins The Research Acceleration and Innovation Network

May 13, 2015
Posted in , ,

Cure SMA has become a participating organization of The Research Acceleration and Innovation Network (TRAIN), a program of FasterCures, bringing the total number of venture […]

Update on SMA-FDA Interactions

May 11, 2015
Posted in , , ,

The SMA drug pipeline has grown dramatically in just over a decade. Of the 17 programs in the pipeline, seven of these are in clinical […]

2015 Family Friendly Poster Session Presenters Announced

May 8, 2015
Posted in ,

The Family Friendly Research Poster Session is one of the most anticipated events of our Annual SMA Conference. Each year, Cure SMA invites researchers from […]

Update on Clinical Development of RG7800

May 7, 2015
Posted in ,

F. Hoffman-La Roche, PTC and the SMA Foundation recently provided an update on the clinical development of RG7800, an investigational SMN2 splicing modifier that is […]

Scroll to Top